Avidity Partners Management LP decreased its position in shares of Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 24.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 570,137 shares of the company’s stock after selling 186,028 shares during the […]
Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) Director Halley E. Gilbert sold 18,200 shares of Vaxcyte stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $73.00, for a total value of $1,328,600.00. Following the transaction, the director now owns 5,625 shares in the company, valued at approximately […]
Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) SVP Mikhail Eydelman sold 1,667 shares of the company’s stock in a transaction on Monday, June 3rd. The shares were sold at an average price of $72.06, for a total transaction of $120,124.02. Following the sale, the senior vice president now owns 31,161 shares of the company’s stock, […]
Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) CEO Grant Pickering sold 2,616 shares of the business’s stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $72.06, for a total transaction of $188,508.96. Following the transaction, the chief executive officer now owns 144,746 shares in the company, valued […]
Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) SVP Mikhail Eydelman sold 1,667 shares of the stock in a transaction that occurred on Monday, June 3rd. The stock was sold at an average price of $72.06, for a total transaction of $120,124.02. Following the transaction, the senior vice president now owns 31,161 shares in the company, […]